Michael A Morse Selected Research

CDX 1307

7/2011	Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients.
6/2011	CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Morse Research Topics

Disease

155	Neoplasms (Cancer) 12/2024 - 01/2002
38	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 12/2005
20	Breast Neoplasms (Breast Cancer) 12/2024 - 02/2003
14	Colonic Neoplasms (Colon Cancer) 01/2021 - 06/2003
13	Adenocarcinoma 02/2024 - 01/2002
11	Pancreatic Neoplasms (Pancreatic Cancer) 02/2024 - 01/2002
11	Neoplasm Metastasis (Metastasis) 02/2016 - 06/2003
10	Melanoma (Melanoma, Malignant) 12/2016 - 12/2005
7	Microsatellite Instability 01/2020 - 01/2016
6	Diarrhea 01/2020 - 04/2006
5	Inflammatory Breast Neoplasms 02/2024 - 01/2008
5	Carcinoma (Carcinomatosis) 12/2023 - 07/2005
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2022 - 01/2015
5	Fatigue 09/2021 - 04/2006
5	Rectal Neoplasms (Rectal Cancer) 12/2007 - 03/2004
4	Hypoxia (Hypoxemia) 01/2020 - 04/2007
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 02/2005
4	Disease Progression 01/2019 - 07/2016
4	Ovarian Neoplasms (Ovarian Cancer) 08/2015 - 10/2009
4	Hepatocellular Carcinoma (Hepatoma) 09/2012 - 01/2002
4	Hypersensitivity (Allergy) 06/2011 - 05/2005
3	Cholangiocarcinoma 02/2024 - 01/2009
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2007
3	Brain Neoplasms (Brain Tumor) 10/2021 - 08/2003
3	Nausea 01/2020 - 04/2006
3	Carcinoid Tumor (Carcinoid) 01/2020 - 01/2015
3	Vomiting 01/2020 - 12/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 02/2016
3	Lung Neoplasms (Lung Cancer) 01/2013 - 09/2006
3	Exanthema (Rash) 07/2012 - 04/2006
3	Wilms Tumor (Wilm's Tumor) 06/2010 - 02/2007
3	Fowlpox 08/2008 - 04/2005
2	Inflammation (Inflammations) 02/2024 - 01/2017
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2023 - 08/2023
2	Anemia 01/2023 - 01/2020
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 09/2007
2	Hyperglycemia 01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

34	AntigensIBA 01/2023 - 07/2002
32	VaccinesIBA 12/2024 - 08/2005
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2003
16	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 01/2002
16	Immune Checkpoint InhibitorsIBA 01/2023 - 06/2015
16	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 05/2005
16	Capecitabine (Xeloda)FDA Link 01/2021 - 05/2005
16	Bevacizumab (Avastin)FDA Link 08/2014 - 05/2005
15	Carcinoembryonic AntigenIBA 12/2023 - 01/2002
15	Cancer VaccinesIBA 01/2021 - 02/2005
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2005
11	Monoclonal AntibodiesIBA 01/2020 - 08/2007
9	AntibodiesIBA 01/2022 - 06/2010
9	CytokinesIBA 10/2021 - 09/2007
9	Peptides (Polypeptides)IBA 03/2019 - 02/2003
8	IpilimumabIBA 02/2024 - 12/2005
8	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 03/2004
8	Messenger RNA (mRNA)IBA 06/2021 - 01/2002
8	Interleukin-2 (IL2)IBA 11/2019 - 07/2009
7	NivolumabIBA 02/2024 - 07/2016
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2008
6	Everolimus FDA Link 01/2018 - 01/2011
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 04/2007
6	Cetuximab (Erbitux)FDA Link 06/2011 - 04/2006
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 09/2007
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2005
5	Panitumumab (Vectibix)FDA Link 01/2021 - 01/2011
5	AutoantigensIBA 05/2015 - 08/2007
4	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2024 - 01/2008
4	Gemcitabine FDA Link 01/2023 - 12/2009
4	ensituximabIBA 01/2023 - 06/2013
4	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2019
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019 - 12/2016
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2019 - 09/2002
4	Tyrosine Kinase InhibitorsIBA 02/2015 - 06/2010
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022 - 01/2020
3	Lapatinib (GW572016)FDA Link 01/2021 - 06/2010
3	lonafarnib (SCH 66336)IBA 07/2012 - 02/2011
3	EpitopesIBA 05/2011 - 04/2009
2	birinapantIBA 02/2024 - 01/2013
2	Leucovorin (Folinic Acid)FDA Link 01/2023 - 08/2005
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2022 - 01/2015
2	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2020
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2019
2	Interleukin-6 (Interleukin 6)IBA 10/2021 - 07/2011
2	cabozantinibIBA 01/2021 - 01/2018
2	telotristat ethylIBA 01/2020 - 01/2020
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020 - 11/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 08/2014
2	BilirubinIBA 01/2020 - 05/2011
2	pembrolizumabIBA 11/2019 - 05/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019 - 08/2015

Therapy/Procedure

67	Therapeutics 12/2024 - 01/2002
48	Immunotherapy 01/2022 - 01/2002
40	Drug Therapy (Chemotherapy) 12/2022 - 07/2005
14	Radiotherapy 12/2022 - 03/2004
8	Chemoradiotherapy 11/2011 - 01/2002
5	Adjuvant Chemotherapy 08/2023 - 11/2006
3	Hepatectomy 07/2009 - 03/2007
2	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2020
2	Blood Component Removal (Apheresis) 12/2019 - 05/2019